Talk:Vasodilatory shock
![]() | This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||||
|
About the mortality issue
[edit]About the mortality,the "Prognosis" in the infobox said "Higher than 50% mortality rate within a month", and the Prognosis section said "Refractory shock has an all-cause mortality rate greater than 50% within a month". The reference is Outcome of patients with septic shock and high-dose vasopressor therapy.
It seems to be about Septic shock, instead of Vasodilatory shock. Is it ok to be a reference of mortality of Vasodilatory shock?--Wolfch (talk) 05:02, 26 February 2019 (UTC)
Contested deletion
[edit]This page should not be speedy deleted as an unambiguous copyright infringement, because MedlinePlus Health topic or work from National Health Institute are in public domain. --It's gonna be awesome!✎Talk♬ 08:17, 27 February 2019 (UTC)
Most of the information on the NHLBI website is in the public domain and can be used without restriction. The NHLBI asks only that no changes be made to the publications, videos, images, or other formatted multimedia products and that the material, as well any NHLBI webpage links, not be used in any direct or indirect product endorsement or advertising.There are a few exceptions. For example, some resources, such as some images on the NHLBI website, have been licensed by a third party and are restricted in their use. Generally, copyrighted materials will include a copyright statement. If in doubt, please write to the contact for that site.
https://www.nhlbi.nih.gov/about/contact/trademark-branding-and-logo --It's gonna be awesome!✎Talk♬ 08:44, 27 February 2019 (UTC)